Likely active: new fund Apr 2023 Verified 5 Nov 2026
Outcomes Collective Growth Capital
Austin, TX investor in growth-stage technology and tech-enabled services companies in healthcare and education, typically investing $1m to $5m in Series A to C rounds alongside family office LPs.
- Type
- VC firm
- Location
- Austin, Texas, United States
- Stages
- Series A, Series B, Growth
- Backs
- Medtech and digital health
- Sectors
- Healthtech and life sciences, Edtech
- Fund size / AUM
- Fund size not disclosed on Form D
- Latest fund or filing
- 24 Apr 2023
- Website
- outcomescollective.com
Contacts on file
For Outcomes Collective Growth Capital, the paid file holds: 4 named decision-makers with roles; LinkedIn page.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Sources
- www.sec.gov/Archives/edgar/data/1974626/000197462623000001/
- www.outcomescollective.com/
- www.outcomescollective.com/about-us
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 35 lists
Series A investors in Texas (15)Series B edtech investors (15)Series A edtech investors in the US (21)Healthtech investors in Austin (23)Medtech investors in Texas (25)Growth-stage edtech investors (29)Series B medtech investors in the US (36)Healthtech investors in Texas (42)Series B medtech investors (57)Series A edtech investors (58)Series B healthtech investors in the US (69)Growth-stage medtech investors in the US (69)Series A medtech investors in the US (76)Edtech venture capital firms in the US (83)Venture capital firms in Austin (95)Growth-stage medtech investors (107)Growth-stage healthtech investors in the US (121)Series A medtech investors (125)Edtech investors (153)Series B healthtech investors (160)Series A healthtech investors in the US (164)Series B investors in the US (165)Venture capital firms in Texas (181)Growth-stage investors in the US (288)Growth-stage healthtech investors (316)Series B investors (339)Medtech venture capital firms in the US (350)Series A investors in the US (372)Series A healthtech investors (401)Medtech investors (457)Growth-stage investors (705)Healthtech venture capital firms in the US (709)Series A investors (864)Healthtech investors (1,207)Venture capital firms in the US (2,975)